Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?

J. H. M. Driessen*, L. M. Knapen, P. P. M. M. Geusens, J. P. W. van den Bergh

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

3 Citations (Web of Science)
34 Downloads (Pure)
Original languageEnglish
Pages (from-to)2429-2430
Number of pages2
JournalOsteoporosis International
Issue number8
Publication statusPublished - Aug 2017

Cite this